Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Notable Analyst Rating Changes 01/29: (GSK) (HOV) (ERIC) Upgraded; (VMW) (MGM) (FTNT) Downgraded
-
StreetInsider.com's Stocks for an Obama Victory
-
Deutsche Bank Maintains a 'Hold' on Laboratory Corporation of America (LH); Leveraged Buy-out Model
-
Deutsche Bank Downgrades Laboratory Corporation of America (LH) to Hold; Finding it Harder to Stay Positive on Shares
-
Daily State of the Markets 01/18: Has 'That Something' Arrived?
-
Lab Corp. (LH) Traders Taking Profits Today; Citi Cuts to Hold Following Closing of Genzyme Deal
-
Daily State of the Markets 12/01: Questioning The Timing
-
Deutsche Bank Upgrades Laboratory Corporation of America (LH) to Buy; Rolling Out 2012 Rstimates
-
Deutsche Bank Maintains a 'Hold' on Genzyme (GENZ); Genetics Sale-More Upside if Diagnostics Sold
-
Deutsche Bank Downgrades LabCorp of America (LH) to Hold; Risk/Reward More Balanced
-
Deutsche Bank Starts Laboratory Corp. (LH) and Quest Diagnostics (DGX) at Buy
-
David Moenning's Daily State of the Markets: 10/23
-
Pre-Open Movers 7/24: QUALCOMM (QCOM) Surges On Nokia Settlement; Chipotle (CMG) Sinks On Results
